BiotechTubeBiotechTube
Home/Immunic/Dr. Monika B. Toernquist, Ph.D.
DM

Dr. Monika B. Toernquist, Ph.D.

Board Director

Immunic

Therapeutic Areas

Autoimmune DiseasesNeurologyGastroenterologyInflammatory Diseases

Immunic Pipeline

DrugIndicationPhase
Vidofludimus calcium (IMU-838)Relapsing-Remitting Multiple Sclerosis (RRMS)Phase 3
IMU-856Crohn's Disease (CD)Phase 1b
IMU-381 / IMU-935Oncology / Inflammatory DiseasesPreclinical

Leadership Team at Immunic

DD
Dr. Daniel Vitt, Ph.D.
Chief Executive Officer, President, and Director
DA
Dr. Andreas Muehler, M.D.
Chief Medical Officer
DD
Dr. Duane Nash, M.D., J.D., M.B.A.
Chairman of the Board
DH
Dr. H. Daniel Perez
Board Director
DS
Dr. Sanjay S. Patel, J.D.
Board Director
DB
Dr. Barbara L. Klencke, M.D.
Board Director
DS
Dr. Sven Rohmann, M.D., Ph.D.
Chief Financial Officer
DW
Dr. Werner Tschollar
Head of Development
DA
Dr. Andreas Rauch, Ph.D.
Head of Research
View full Immunic profile